COSYNE THERAPEUTICS Trademark

Trademark Overview


On Wednesday, May 25, 2022, a trademark application was filed for COSYNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the COSYNE THERAPEUTICS trademark a serial number of 97427191. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 5, 2024. This trademark is owned by CoSyne Therapeutics Limited. The COSYNE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, neurological and oncological pharmaceutical products; Pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer

Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development purposes
cosyne therapeutics

General Information


Serial Number97427191
Word MarkCOSYNE THERAPEUTICS
Filing DateWednesday, May 25, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "COSYNE"over the stylized wording "THERAPEUTICS" with the design of a DNA helix forming the letter "Y" extending downward to also form the letter "A".
Goods and ServicesPharmaceuticals, namely, neurological and oncological pharmaceutical products; Pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDrug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoSyne Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Party NameCoSyne Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Trademark Events


Event DateEvent Description
Thursday, June 2, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, May 28, 2022NEW APPLICATION ENTERED
Wednesday, June 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2024SOU EXTENSION 2 GRANTED
Friday, July 5, 2024SOU EXTENSION 2 FILED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU EXTENSION 1 FILED
Thursday, January 4, 2024SOU EXTENSION 1 GRANTED